Literature DB >> 15729290

Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats.

Jin Zhou1, Hiromichi Ando, Miroslava Macova, Jingtao Dou, Juan M Saavedra.   

Abstract

Endothelial dysfunction and inflammation enhance vulnerability to hypertensive brain damage. To explore the participation of Angiotensin II (Ang II) in the mechanism of vulnerability to cerebral ischemia during hypertension, we examined the expression of inflammatory factors and the heat shock protein (HSP) response in cerebral microvessels from spontaneously hypertensive rats and their normotensive controls, Wistar Kyoto rats. We treated animals with vehicle or the Ang II AT(1) receptor antagonist candesartan, 0.3 mg/kg/day, via subcutaneously implanted osmotic minipumps for 4 weeks. Spontaneously hypertensive rats expressed higher Angiotensin II AT(1) receptor protein and mRNA than normotensive controls. Candesartan decreased the macrophage infiltration and reversed the enhanced tumor necrosis factor-alpha and interleukin-1beta mRNA and nuclear factor-kappaB in microvessels in hypertensive rats. The transcription of many HSP family genes, including HSP60, HSP70 and HSP90, and heat shock factor-1 was higher in hypertensive rats and was downregulated by AT(1) receptor blockade. Our results suggest a proinflammatory action of Ang II through AT(1) receptor stimulation in cerebral microvessels during hypertension, and very potent antiinflammatory effects of the Ang II AT(1) receptor antagonist. These compounds might be considered as potential therapeutic agents against ischemic and inflammatory diseases of the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15729290     DOI: 10.1038/sj.jcbfm.9600082

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  43 in total

Review 1.  Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2011-09-22       Impact factor: 5.046

Review 2.  The discovery of a novel macrophage binding site.

Authors:  Juan M Saavedra; Jaroslav Pavel
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

Review 3.  Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT( 1 ) Receptor Antagonists in the Brain.

Authors:  Juan M Saavedra; Julius Benicky; Jin Zhou
Journal:  Cell Mol Neurobiol       Date:  2006-04-25       Impact factor: 5.046

Review 4.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

5.  Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury.

Authors:  Jin Zhou; Jie Li; Daniel M Rosenbaum; Frank C Barone
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

Review 6.  Fimasartan: A New Angiotensin Receptor Blocker.

Authors:  Hae-Young Lee; Byung-Hee Oh
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

Review 7.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

Review 8.  Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions.

Authors:  Yong Li; Pablo Gonzalez; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2012-05-22       Impact factor: 11.685

9.  Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury.

Authors:  Yan-Hua Sang; Huan-Xing Su; Wu-Tian Wu; Kwok-Fai So; Raymond Tak-Fai Cheung
Journal:  J Neurotrauma       Date:  2011-10-11       Impact factor: 5.269

10.  Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system.

Authors:  Nicolas Pelisch; Naohisa Hosomi; Masaki Ueno; Hisashi Masugata; Koji Murao; Hirofumi Hitomi; Daisuke Nakano; Hiroyuki Kobori; Akira Nishiyama; Masakazu Kohno
Journal:  Hypertens Res       Date:  2009-11-27       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.